Host Katherine Ellen Foley talks with Robert King about some House Republicans’ opposition to a cost-cutting proposal from the Center for Medicare and Medicaid Innovation that would reduce payments for drugs that have won FDA approval but haven’t yet proven their clinical benefit. The GOP representatives argue it will curtail innovation and access to promising therapies.

Learn more about your ad choices. Visit megaphone.fm/adchoices